Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Size: px

Start display at page:

Download "Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type."

Elwin Sims
5 years ago
Views:

1 Note: Page numbers of article titles are in boldface type. A Acute myocardial infarction contemporary DES platforms in patients with, 290 AF. See Atrial fibrillation (AF) African Americans dietary factors effects on, hypertension in, management of, Age of FMD diagnosis, Air pollutants BP effects of, Alcohol consumption moderation of BP effects of, 202 ALLHAT trial. See Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack (ALLHAT) trial Altitude(s) high BP effects of, 216 Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack (ALLHAT) trial treatment lessons learned from, 242 Anxiety BP effects of, 226 Atrial fibrillation (AF) left atrial appendage closure device in, See also Left atrial appendage closure, in AF B Baroreceptor activation therapy in resistant hypertension management, Behavioral interventions in BP control, 207 Biomarker screening in heart failure intervention and prevention in stages A and B, 263 Blood pressure (BP) control of behavioral interventions in lifestyle modification in, 207 gene diet interactions in, 206 health care providers in, 208 dietary factors effects on, See also Dietary factors, BP effects of elevated Cardiol Clin 35 (2017) /17 introduction, risk factors associated with, evidence-based guidelines in management of, environmental effects on, See also Environment, BP effects of psychosocial factors effects on, See also Psychosocial factors, BP effects of Blood pressure (BP) regulation genomic variants in rare familial hypertensive syndromes related to, 186, 190 BP. See Blood pressure (BP) C Calcium 205 Cardiac transplantation Cerebrovascular fibromuscular dysplasia (FMD), 252 Children dietary factors effects on, 207 Cholesterol BP effects of, Chronic kidney disease contemporary DES platforms in patients with, 290, 292 Cold ambient temperature Computed tomography angiography (CTA) CTA. See Computed tomography angiography (CTA) D DASH diet BP effects of, DES platforms. See Drug-eluting stent (DES) platforms Diabetes mellitus (DM) contemporary DES platforms in patients with, 292 hypertension management in patients with, Dietary Approaches to Stop Hypertension (DASH) diet BP effects of, cardiology.theclinics.com

2 302 Dietary factors BP effects of, in African Americans, alcohol consumption moderation, 202 in children, 207 DASH diet, dietary patterns, factors with limited or uncertain effects, calcium, cholesterol, fats other than omega-3 polyunsaturated fatty acid, 205 fiber, 204 fish oil supplementation, 204 magnesium, 205 protein, 206 vitamin C, 206 gene diet interactions, 206 increased potassium intake, introduction, Mediterranean diet, 204 multiple dietary changes, in older adults, 207 reduced salt intake, vegetarian diets, 202 weight loss, Dietary patterns BP effects of, DM. See Diabetes mellitus (DM) Doppler ultrasonography in FMD diagnosis, Drug-eluting stent (DES) platforms contemporary, clinical efficacy of, in selected patient populations, commercially available, component design, metallic stent scaffold, released antiproliferative drug, 284 stent polymer coatings, insights from mechanical and device integrity and failure, introduction, longitudinal deformation with, pathologic correlates of stent fracture with, 287 safety outcomes, in selected patient populations, stent fracture with, 286 E Emotional states BP effects of, 226 Endeavor platform, 286 Environment BP effects of, air pollutants, clinical implications of, 218 cold ambient temperature and winter season, high altitudes, 216 loud noises, Essential hypertension, See also Hypertension causes of, 186 control of, 232 identification of, 232 introduction, management of, advances in, ALLHAT trial in, 242 combination therapy in, 236 in diabetics, emerging and future guidelines in, 244 ethnicity-related, introduction, lifestyle modifications in, evidence-based, in older adults, patient-centered care in, pharmacotherapy in, 236 protocol-based, evidence-based guidelines in, perspectives from discovery of 43 variants for by GWAS, 194 prevalence of, 232 Ethnicity-related/race-related stress BP effects of, Everolimus-eluting stents clinical efficacy of, F Familial hypertensive syndromes rare genomic variants in BP regulation and, 186, 190 Fats other than omega-3 polyunsaturated fatty acid BP effects of, 205 Fiber Fibromuscular dysplasia (FMD), diagnosis of age at, extrarenal, cerebrovascular FMD, 252 imaging tests for, 253 in vascular beds, 252 historical perspective, imaging tests for, introduction, from pathologic to angiographic classification of,

3 303 presentations of, 250 prevalence of, progress over last 8 decades, screening for, age of, Fibromuscular renal artery stenosis screening for, Fish oil supplementation FMD. See Fibromuscular dysplasia (FMD) G Gene(s) monogenic hypertension related, Gene diet interactions Genome-wide association studies (GWAS) hypertension and, perspectives from discovery of 43 variants for essential hypertension by, 194 Genomics in hypertension, Genomic variants diseases associated with, 186 GWAS. See Genome-wide association studies (GWAS) H Health care providers in BP control, 208 Heart failure contemporary approaches to patients with, biomarker screening in early intervention and prevention of, 263 future considerations in, 268 ICDs, 263 stage A, stage B, stage C, diagnostic and therapeutic devices, 265 HFpEF related, HFrEF related, lifestyle, diet, and activity modifications, 263 race, ethnicity, and gender factors in, 263 stage D, cardiac transplantation, LVADs, 268 palliative care and hospice therapy, 266 ventricular replacement, costs related to care, 261, hospitalization readmittance for, 273 introduction, , management of implantable hemodynamic monitors in, See also Implantable hemodynamic monitors, in heart failure management monitoring of limitations of current methods, 274 mortality data, 262 prevalence of, 261, 273 Heart failure with preserved ejection fraction (HFpEF) in stage C heart failure contemporary approach to patients with, Heart failure with reduced ejection fraction (HFrEF) in stage C heart failure evidence-based therapies for, newer medical therapies for, 265 HFpEF. See Heart failure with preserved ejection fraction (HFpEF) HFrEF. See Heart failure with reduced ejection fraction (HFrEF) Hospice care in stage D heart failure, 266 Human Genome Project, 186 Hypertension. See also specific types, e.g., Essential hypertension in African Americans, management of, cardiovascular morbidity and mortality data related to, 185 control of advances in, environment and, See also Environment, BP effects of essential See Essential hypertension genomic approaches to, GWAS and, management of in diabetics, emerging and future guidelines in, 244 in older adults, patient-centered care in, evidence-based guidelines in, monogenic See Monogenic hypertension prevalence of, 185, 223, 255 resistant, See also Resistant hypertension secondary, I ICDs. See Implantable cardiac defibrillators (ICDs) Implantable cardiac defibrillators (ICDs) in heart failure management for asymptomatic left ventricular dysfunction due to ischemic heart disease in stages A and B, 263

4 304 Implantable hemodynamic monitors in heart failure management, left atrial pressure monitors, PAP monitors, right ventricular pressure monitors, Inheritable diseases Ischemic heart disease asymptomatic left ventricular dysfunction due to ICDs in management of, 263 L Left atrial appendage closure in AF, case history, 297 costs of, 298 discussion, 298 efficacy of, 298 safety of, Left atrial pressure monitors in heart failure management, Left ventricular assist devices (LVADs) in stage D heart failure, 268 Lifestyle modifications behavioral interventions related to in BP control, 207 in essential hypertension management, evidence-based, Loud noises BP effects of, LVADs. See Left ventricular assist devices (LVADs) M Magnesium BP effects of, 205 Magnetic resonance angiography (MRA) Median nerve modulators in resistant hypertension management, 258 Mediterranean diet Mendelian diseases Monogenic hypertension features of, 190 genes associated with, mechanistic pathways of, 190 Monogenic hypertension syndromes mechanistic pathways of, 190 MRA. See Magnetic resonance angiography (MRA) N Noise BP effects of, O Occupational stress BP effects of, Older adults dietary factors effects on, 207 hypertension management in SPRINT trial in, Overscreening in secondary hypertension balancing of, P Paclitaxel-eluting stents clinical efficacy of, Palliative care in stage D heart failure, 266 PAP monitors. See Pulmonary artery pressure (PAP) monitors Patient-centered care in essential hypertension management, PCI. See Percutaneous coronary intervention (PCI) Percutaneous coronary intervention (PCI) historical background of, 281 Pollutant(s) air BP effects of, Potassium increased intake of BP effects of, Promus Premier platform, 286 Protein Psychosocial factors BP effects of, anxiety, 226 emotional states, 226 interventions for, introduction, occupational stress, race-related/ethnicity-related stress, research priorities related to, 227 SES, 224 social relationships, Pulmonary artery pressure (PAP) monitors in heart failure management, R Race-related/ethnicity-related stress BP effects of, Rare familial hypertensive syndromes genomic variants in BP regulation and, 186, 190 Relationship(s) social

5 305 BP effects of, Renal denervation in resistant hypertension management, Resistant hypertension, device-directed therapy for, baroreceptor activation therapy, future trends in, 258 median nerve modulators, 258 renal denervation, introduction, prevalence of, Resolute Integrity ZES platform, 286 Right ventricular pressure monitors in heart failure management, S Salt reduced intake of BP effects of, Secondary hypertension overscreening and underdiagnosis of balancing of, See also Fibromuscular dysplasia (FMD) SES. See Socioeconomic status (SES) Social relationships BP effects of, Socioeconomic status (SES) BP effects of, 224 SPRINT. See Systolic Blood Pressure Intervention Trial (SPRINT) Stent(s). See specific types Stress BP effects of occupational stress, race-related/ethnicity-related stress, Systolic Blood Pressure Intervention Trial (SPRINT) in essential hypertension management, antihypertensive agents in, 243 T TAXUS platforms, Temperature cold ambient Transplantation U Ultrasonography Doppler Underdiagnosis in secondary hypertension balancing of, See also Fibromuscular dysplasia (FMD) V Vegetarian diets BP effects of, 202 Ventricular replacement Vitamin C W Weight loss BP effects of, Winter season X Xience Alpine platform, 286 Z Zotarolimus-eluting stents clinical efficacy of,

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for